1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
LLA.L,0P0001T9GN,0

LLA.L,0P0001T9GN,0

LLA.L
LLA.L,0P0001T9GN,0GB flagLondon Stock Exchange
LLA.L,0P0001T9GN,0
LLA.L
(London Stock Exchange)

Recent

price

15.00

P/E

ratio

-1.15

div

yld

- -

ROIC.AI

Capital Structure

•

in mil. unless spec.
Working Capital

•

in mil. unless spec.
Growth Rates

•

in mil. unless spec.
Quarterly Revenue

•

in mil. unless spec.
Quarterly Earnings Per Share

•

in mil. unless spec.
Quarterly Dividends Per Share

•

in mil. unless spec.
Similar Companies
Business
LungLife AI, Inc., a diagnostic company, researches and develops clinical diagnostic solutions for lung cancer with artificial intelligence (AI) technology in the United States and the People's Republic of China. The company engages in developing LungLB, a blood-based test to stratify cancerous and benign lung nodules identified by CT scan. The company was formerly known as Cynvenio Biosystems, Inc. and changed its name to LungLife AI, Inc. in May 2019. LungLife AI, Inc. was incorporated in 2009 and is based in Thousand Oaks, California.